Previous Article | Next Article ![]()
Molecular and Cellular Biology, November 1999, p. 7305-7313, Vol. 19, No. 11
Department of Infectious Diseases (Virology),
Imperial College School of Medicine, London W12 0NN, United Kingdom
Received 25 January 1999/Returned for modification 8 March
1999/Accepted 11 August 1999
The exquisite sensitivity of the Burkitt's lymphoma (BL)-derived
cell line Daudi to type I interferons has not previously been
explained. Here we show that expression of an Epstein-Barr virus (EBV)
transcript, designated D-HIT (Y. Gao et al., J. Virol. 71:84-94,
1997), correlates with the sensitivity of different Daudi cell isolates
(or that of other EBV-carrying cells, where known) to alpha interferon
(IFN-
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Sensitivity of an Epstein-Barr Virus-Positive Tumor Line,
Daudi, to Alpha Interferon Correlates with Expression of a
GC-Rich Viral Transcript

and
). D-HIT, transcribed from a GC-rich repetitive region (IR4) of
the viral genome, is highly structured, responding to RNase digestion
in a manner akin to double-stranded RNA. Comparing EBV-carrying BL cell
lines with differing responses to IFN-
, we found the protein levels
of the dsRNA-activated kinase, PKR, to be similar, whereas the levels of the autophosphorylated active form of PKR varied in a manner that
correlated with endogenous levels of D-HIT expression. In a classical
in vitro kinase assay, addition of either poly(I)-poly(C) or an in
vitro-transcribed D-HIT homolog stimulated the autophosphorylation activity of PKR from IFN-
-treated cells in both EBV-positive and
EBV-negative B lymphocytes. By transfection experiments, these RNAs
were shown to reduce cell proliferation and to sensitize otherwise
relatively insensitive Raji cells to IFN-
. The data lead to a model
wherein the D-HIT viral RNA also serves as a possible transcriptional
activator of IFN-
or cellular genes regulated by this cytokine.
*
Corresponding author. Present address: Viral Oncology
Unit, Division of Medicine, Imperial College of Medicine, St. Mary's site, Norfolk Place, London W2 1PG, United Kingdom. Phone: 44 171 594 3670. Fax: 44 171 402 1037. E-mail: bgriffin{at}ic.ac.uk.
Present address: Cancer Research Institute, CAMS, Beijing 100021, People's Republic of China.
Present address: Viral Oncology Unit, Division of Medicine,
Imperial College of Medicine, London W2 1PG, United Kingdom.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»